Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Katz, R.J.
Roth, K.A.
and
Schmaltz, K.
1981.
Amphetamine and tranylcypromine in an animal model of depression: Pharmacological specificity of the reversal effect.
Neuroscience & Biobehavioral Reviews,
Vol. 5,
Issue. 2,
p.
259.
Woodcock, A A
Gross, E R
and
Geddes, D M
1981.
Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers..
BMJ,
Vol. 283,
Issue. 6287,
p.
343.
McLean, P.C.
and
Casey, Patricia
1982.
Drugs in Psychiatric Practice.
p.
321.
Tyrer, P.J.
1982.
Drugs in Psychiatric Practice.
p.
249.
Bélanger, Pierre-M.
and
Atitsé-Gbeassor, Ameyo
1982.
Inhibitory effect of tranylcypromine on hepatic drug metabolism in the rat.
Biochemical Pharmacology,
Vol. 31,
Issue. 16,
p.
2679.
Tyrer, Peter
1984.
Clinical effects of abrupt withdrawal from tri-cyclic antidepressants and monoamine oxidase inhibitors after long-term treatment.
Journal of Affective Disorders,
Vol. 6,
Issue. 1,
p.
1.
Lejoyeux, M.
and
Ades, J.
1989.
Le syndrome de sevrage des antidépresseurs.
Psychiatry and Psychobiology,
Vol. 4,
Issue. 6,
p.
335.
O'Brien, Sinead
and
McKeon, Patrick
1990.
Current issues in monoamine oxidase inhibitor treatment.
Irish Journal of Psychological Medicine,
Vol. 7,
Issue. 2,
p.
159.
Baumbacher, Gordon
and
Hansen, Mary Susan
1992.
Abuse of Monoamine Oxidase Inhibitors.
The American Journal of Drug and Alcohol Abuse,
Vol. 18,
Issue. 4,
p.
399.
Theret, L
Bertholon, F
and
Germain, MC
1992.
Two cases of mianserin abuse in psychiatric out-patients.
European Psychiatry,
Vol. 7,
Issue. 3,
p.
143.
Gerlach, M.
Riederer, P.
Schoerlin, M. P.
Guentert, T. W.
Waldmeier, P.
Kettler, R.
Cesura, A.
Richards, J. G.
Da Prada, M.
Laux, G.
Becker, T.
Bieck, P. R.
and
Schmauß, M.
1993.
Neuro-Psychopharmaka.
p.
269.
Yonemitsu, Kosei
and
Pounder, Derrick J.
1993.
Postmortem changes in blood tranylcypromine concentration: Competing redistribution and degradation effects.
Forensic Science International,
Vol. 59,
Issue. 2,
p.
177.
Haddad, Peter
1999.
Do antidepressants have any potential to cause addiction?.
Journal of Psychopharmacology,
Vol. 13,
Issue. 3,
p.
300.
Gerlach, M.
Riederer, P.
Martin, J. R.
Amrein, R.
Waldmeier, P. C.
Kettler, R.
Borroni, E.
Cesura, A.
Grünblatt, E.
Jorga, K.
Richards, J. G.
Da Prada, M.
Laux, G.
Becker, T.
Müller, U.
Müller, U.
Laux, G.
Bieck, P. R.
Schmauss, M. P.
and
Guentert, T. W.
2002.
Neuro-Psychopharmaka Ein Therapie-Handbuch.
p.
437.
Brust, John C.M.
2004.
Neurological Aspects of Substance Abuse.
p.
105.
Lôo, H.
and
Olié, J.-P.
2004.
Effets secondaires des antidépresseurs.
EMC - Psychiatrie,
Vol. 1,
Issue. 4,
p.
1.
Lôo, H.
and
Olié, J.-P.
2004.
Effets secondaires des antidépresseurs.
EMC - Psychiatrie,
Vol. 1,
Issue. 4,
p.
294.
Papakostas, George I.
and
Fava, Maurizio
2005.
Biology of Depression.
p.
87.
Baghai, Thomas C
Eser, Daniela
Schule, Cornelius
Born, Christoph
and
Rupprecht, Rainer
2007.
Selegiline transdermal system in the treatment of depressive disorders.
Future Neurology,
Vol. 2,
Issue. 6,
p.
601.
Brust, John C.M.
2007.
Aspects neurologiques de l'addiction.
p.
129.
eLetters
No eLetters have been published for this article.